Spatial Inhomogeneity of Cardiac Norepinephrine Transport Protein and Meta-[123I]Iodobenzylguanidine Uptake in Swine Myocardial Tissue
- 30 Downloads
The aim of the present study was to evaluate the expression of the cardiac norepinephrine transporter (NET) in the left ventricle (LV) of healthy pigs and its relationship with regional meta-[123I]iodobenzylguanidine ([123I]MIBG) myocardial uptake.
Experiments were performed on animals injected with [123I]MIBG and acquired 2 h later using an ultrafast CZT gamma camera to assess the regional myocardial uptake. After image acquisition, animals were euthanized; the heart was quickly excised and underwent to an ex vivo single photon emission tomography (SPECT) imaging. Four small samples of tissue were then harvested from mid-walls and apex of the left ventricle; NET densities were evaluated and further normalized for protein loading per cardiac region.
Three variants of NET protein with different molecular weights were detected. The expression of NET was not homogenous in the LV, with the highest density in the inferior wall and the lowest one in the apical area. The regional in vivo [123I]MIBG uptake revealed an analogous trend, showing a good linear relationship with NET expression. Parallel results were obtained from the ex vivo study.
This study elucidates the expression of three different variants of NET proteins into the left ventricular myocardium of a healthy pig. NET expression into the LV was not homogeneous and paralleled by differences in regional [123I]MIBG uptake. Moreover, the correlation and the agreement between measurements of regional expression of NET variants and [123I]MIBG uptake represent a relevant finding for inferences about NET expression in the context of clinical imaging.
Key wordsNET [123I]MIBG CZT Cardiac sympathetic innervation Ultrafast cardiac camera
Compliance with Ethical Standards
All regulatory aspects for laboratory animal care were followed; the study was performed fully in accordance with the European Directive (2010/63/UE) and the Italian law (D.L 26/2014). The study was approved by the Ethical Committee of Experimental Biomedicine Centre, National Research Council, Pisa, Italy, and by the competent national authority (Italian Ministry of Health).
Conflict of Interest
The authors declare that they have no conflict of interest.
- 3.Melikian HE, McDonald JK, Gu H, Rudnick G, Moore KR, Blakely RD (1994) Human norepinephrine transporter. Biosynthetic studies using a site-directed polyclonal antibody. J Biol Chem 269:12290–12297Google Scholar
- 4.Melikian HE, Ramamoorthy S, Tate CG, Blakely RD (1996) Inability to Nglycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition. Mol Pharmacol 50:266–276Google Scholar
- 8.Wehrwein EA, Parker LM, Wright AA, Spitsbergen JM, Novotny M, Babankova D, Swain GM, Habecker BA, Kreulen DL (2008) Cardiac norepinephrine transporter protein expression is inversely correlated to chamber norepinephrine content. Am J Physiol Regul Integr Comp Physiol 295:R857–R863CrossRefGoogle Scholar
- 10.Kreiner G, Wolzt M, Fasching P, Leitha T, Edlmayer A, Korn A, Waldhausl W, Dudczak R (1995) Myocardial m-[123I]iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM. Comparison with cardiovascular reflex tests and relationship to left ventricular function. Diabetes 44:543–549CrossRefGoogle Scholar
- 11.Hattori N, Tamaki N, Hayashi T et al (1996) Regional abnormality of iodine-123-MIBG in diabetic hearts. J Nucl Med 1996(37):1985–1990Google Scholar
- 13.Satoh A, Serita T, Seto M, Tomita I, Satoh H, Iwanaga K, Takashima H, Tsujihata M (1999) Loss of 123I-MIBG uptake by the heart in Parkinson’s disease: assessment of cardiac sympathetic denervation and diagnostic value. J Nucl Med 40:371–375Google Scholar
- 14.Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, Agostini D, Weiland F, Chandna H, Narula J, ADMIRE-HF Investigators (2010) ADMIRE-HF investigators. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView myocardial imaging for risk evaluation in heart failure) study. J Am Coll Cardiol 55:2212–2221CrossRefGoogle Scholar
- 17.Kusmic C, Morbelli S, Marini C, Matteucci M, Cappellini C, Pomposelli E, Marzullo P, L'Abbate A, Sambuceti G (2008) Whole-body evaluation of MIBG tissue extraction in a mouse model of long-lasting type II diabetes and its relationship with norepinephrine transport protein concentration. J Nucl Med 49:1701–1706CrossRefGoogle Scholar
- 24.Pierpont GL, DeMaster EG, Reynolds S, Pederson J, Cohn JN (1985) Ventricular myocardial catecholamines in primates. J Lab Clin Med 106:205–210Google Scholar
- 25.Tsuchimochi S, Tamaki N, Tadamura E, Kawamoto M, Fujita T, Yonekura Y, Konishi J (1995) Age and gender differences in normal myocardial adrenergic neuronal function evaluated by iodine-123-MIBG imaging. J Nucl Med 36(6):969–974Google Scholar
- 26.Morozumi T, Kusuoka H, Fukuchi K, Tani A, Uehara T, Matsuda S, Tsujimura E, Ito Y, Hori M, Kamada T, Nishimura T (1997) Myocardial iodine-123-metaiodobenzylguanidine images and autonomic nerve activity in normal subjects. J Nucl Med 38(1):49–52Google Scholar
- 27.Yoshinaga K, Tomiyama Y, Manabe O, Kasai K, Katoh C, Magota K, Suzuki E, Nishijima KI, Kuge Y, Ito YM, Tamaki N (2014) Prone-position acquisition of myocardial 123I-metaiodobenzylguanidine (MIBG) SPECT reveals regional uptake similar to that found using (11)C-hydroxyephedrine PET/CT. Ann Nucl Med 28:761–769CrossRefGoogle Scholar